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Executive Summary
INTRODUCTION
The progesterone vaginal ring (PVR) is a ring-shaped device used by postpartum women to extend the
contraceptive effectiveness of lactational amenorrhea. The ring is inserted in the vagina 6–9 weeks
postpartum (for study purposes; 30–90 days in normal service delivery settings) for continuous use for
up to 3 months and replaced with a new one if breastfeeding is continued and extended contraception is
desired. The ring diffuses a continuous flow of low-dose progesterone through the vaginal walls, which
enters the bloodstream and regulates the woman’s fertility by suppressing ovulation. Previous studies
have shown that contraceptive vaginal rings are safe, effective, and well accepted in varied cultural
settings. However, the extent to which the ring is acceptable in the sub-Saharan African context is
unknown, especially since vaginal rings are a new technology and use of vaginal products such as
tampons is limited in the region.

STUDY OBJECTIVES
This study examined the acceptability of PVR in Kenya as part of a larger project that was also conducted
in Nigeria and Senegal. The specific objectives of the study were to assess the factors influencing the
acceptability of the method among clients, their spouses, providers, community members, and those who
were counseled on but did not choose the method.

METHODS
The study involved prospective follow-up of participants who chose the ring (PVR users) for up to 6
months or two ring cycles, interviews with providers at baseline and endline, as well as cross-sectional
interviews with women who were counseled on but did not choose the ring (PVR nonusers) and key
stakeholders. A total of 60 PVR users were enrolled for follow-up, another 5 PVR users were enrolled for
in-depth interviews, and 58 nonusers were interviewed upon exit. Data collection involved completion of
case record forms by providers during enrollment; quantitative exit interviews with clients during
enrollment, at 3 months, and at 6 months following ring use or at discontinuation; quantitative exit
interviews with PVR nonusers; in-depth interviews with a subset of PVR users at 1 month, 3 months, and
6 months following ring use; in-depth interviews with spouses of PVR users at endline; focus group
discussions with community leaders at endline; and self-administered interviews with providers at
baseline and endline. Analysis of the quantitative data entailed simple frequencies. Directed content
analysis techniques were employed for analyzing the qualitative data.

KEY FINDINGS


Acceptability of the ring: The majority of participants who completed the two ring cycles indicated that they
would use the ring in the future (92%), their partners or family members would support future use (87%),
they would recommend or had already recommended the ring to their friends or family members (92% and
73%, respectively), and that they were willing to pay for the method (77%). In addition, some participants
were encouraged by their spouses to use the ring. There were also remarkable positive changes between
baseline and follow-up in the perceptions of participants and providers about the ring.



Reasons for choosing the ring: The most commonly cited reason for choosing the ring among users was
that the method is user-controlled (49%). The second major reason was perceived fewer side effects
(46%). In addition, some participants chose the ring just to try a new method (14%), while others chose it
because their preferred method was not available at the time of the visit (5%). Most users also found the
ring easy to insert, remove, and reinsert.
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Client profile: The majority of women who chose the ring were aged 20–29 years (77%), had at least
secondary level education (60%), and resided in urban or peri-urban areas (67%). In addition, the majority
of PVR users had given birth to at least 2 children (54%) and wanted to space the next birth by at least 4
years (71%).



Prior use of family planning: Slightly more than one-third of PVR users (37%) were new family planning
users. Among women who had previously used a method, the methods ever used were pills (55%),
injectables (45%), implants (10%), emergency contraceptive pills (8%), male condoms (5%), intrauterine
contraceptive devices—IUDs (5%), and female condoms (3%).



Subsequent method choice: Those who completed two ring cycles were more likely to switch to implants
and intrauterine contraceptive devices (IUDs) compared with those who terminated use (57% versus 17%
for implants and 25% versus 6% for IUDs). Switching to long-term methods was also consistent with the
finding that most users desired to space the next pregnancy by at least 4 years.



Discontinuation of use: Participants who discontinued use of the ring did so for various reasons including
ring expulsion, experiencing side effects, nonadherence to use instructions, opposition by mother-in-law,
husband/partner discomfort during sex, misconception about the method, and experiencing a serious
adverse event.

IMPLICATIONS


The findings of the study indicate that the ring was acceptable to most clients and key stakeholders. In
addition, several positive attributes of the ring that were mentioned by participants are likely to increase
uptake of the method.



The profile of PVR users suggests that young, educated, urban or peri-urban dwellers are likely to be the
first acceptors of the method if it is introduced into the country before it diffuses to other segments of the
population.



The reasons given for choosing the ring and the fact that about one-third of the participants were new
users suggest that the method is likely to expand contraceptive choice during the postpartum period,
enhance women’s autonomy in contraceptive use, and sustain or contribute to an increased contraceptive
prevalence rate in the country.



The finding that those who completed the two ring cycles mostly switched to long-term methods at the end
of the study and that most users desired longer birth spacing suggests that programs delivering the ring
need to consider mechanisms for bridging users to long-term methods.



Given that the ring is a user-controlled method, service-delivery programs should consider ways of
ensuring that clients obtain information on correct use, including proper insertion and adherence to use
instructions, such as not leaving the ring out for long. Proper insertion and adhering to use instructions
are, in turn, likely to reduce instances of ring expulsion and discontinuation.
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Introduction
The progesterone vaginal ring (PVR) is used to extend the contraceptive effectiveness of lactational
amenorrhea among breastfeeding women. The ring is inserted in the vagina 6–9 weeks postpartum for study
purposes (30–90 days in normal service delivery conditions) for continuous use for up to 3 months and
replaced with a new one if breastfeeding is continued and extended contraception is desired. Women can use
four rings successively for up to one year postpartum. PVR functions by diffusing a continuous flow of
progesterone through the vaginal walls—approximately 10 mg per day—which then enters the bloodstream and
regulates the woman’s fertility by suppressing ovulation. Progesterone also thickens the cervical mucus
thereby inhibiting sperm penetration into the uterus. Clinical trials have demonstrated that PVR is an effective
contraceptive method (Sivin et al. 1997; Massai et al. 1999). The method was first registered in Chile and Peru
in 1998 for use by postpartum women but has since been expanded to other Latin American countries,
including Bolivia, the Dominican Republic, Ecuador, and Guatemala (Reproductive Health Supplies Coalition
[RHSC] 2011).
Previous studies conducted by the Population Council have demonstrated that vaginal rings are well accepted
in settings as culturally diverse as Australia, Egypt, Latin America, Singapore, and the United States (RHSC
2011). However, the extent to which PVR is acceptable in the sub-Saharan African context is unknown,
especially since vaginal rings are a new technology in this setting and use of vaginal products such as tampons
is limited in the region. An understanding of the acceptability of the ring is important for informing the
introduction of the method in the region. Sub-Saharan Africa in particular presents an opportunity for
expanding the use of the method given relatively long breastfeeding durations; high unmet need for
contraception, especially during the postpartum period; and the potential for multiple channels of introducing
the method to potential users, including public and private clinics as well as private pharmacies and
community distribution systems (Haggerty and Rutstein 1999; Westoff 2012). Moreover, since the use of PVR
is predicated upon women breastfeeding at least four times a day, it provides an opportunity to promote
breastfeeding while ensuring contraceptive protection, thereby benefiting both mothers and their infants.
To understand the extent of acceptability of the method in the region, the Population Council conducted
acceptability studies in Kenya, Nigeria, and Senegal. This report presents findings from the study in Kenya. The
study was one component of a number of activities aimed at informing the introduction of the method in the
country. Other activities included global and national consultations with key stakeholders, assessments and
documentation of the regulatory and procurement frameworks, and market segmentation and demand
analysis.

STUDY OBJECTIVES
This study examined the acceptability of PVR in Kenya as part of a larger project that was also conducted in
Nigeria and Senegal. The specific objective of the study was to assess the factors influencing the acceptability
of the method among clients, their spouses, providers, community members, and women who were counseled
on but did not choose the method.
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STUDY CONTEXT
Estimates from the Kenya Demographic and Health Surveys (KDHS) show that the contraceptive prevalence
rate (proportion of currently married women using any method of contraception) more than doubled over a
period of a quarter century from 27% in 1989 to 58% in 2014 (National Council for Population and
Development [NCPD] and Institute for Resource Development/Macro Systems 1989; Kenya National Bureau of
Statistics [KNBS] et al. 2015). Over the same period, the use of modern methods increased almost three-fold
from 18% in 1989 to 53% in 2014 (NCPD and Institute for Resource Development/Macro Systems 1989;
KNBS et al. 2015). In spite of the improvements, contraceptive use remained lower than the national average
in rural areas. Contraceptive use was also lowest among young women aged 15–19 years, those with no
education, and those from the poorest households. In addition, estimates from the 2008–09 KDHS showed
that only 25% of postpartum women were using a family planning method compared with the national
contraceptive prevalence rate (CPR) of 46% at that time (Gebreselassie et al. 2008; KNBS and ICF Macro
2010).
Over time, unmet need for contraception declined by almost half from 35% in 1993 to 18% in 2014 (NCPD and
Institute for Resource Development/Macro Systems 1989; KNBS et al. 2015). However, there was only a slight
decline in unmet need between 1998 and 2008–09 from 28% to 26% (NCPD et al. 1999; KNBS and ICF
Macro 2010). In addition, unmet need for contraception remained higher than the national average in rural
areas. Unmet need also remained highest among the youngest age groups (15–24 years), those with low
levels of education (no education and primary incomplete), and those from the poorest households (NCPD et
al. 1999; CBS et al. 2004; KNBS and ICF Macro 2010; KNBS et al. 2015). Estimates from the 2008–09 KDHS
further showed that unmet need was more than twice as high among postpartum women compared with those
in the general population (68% and 26%, respectively) (Gebreselassie et al. 2008; KNBS and ICF Macro 2010).
Trends in contraceptive method mix show that over time, the use of modern methods has been dominated by
injectables—from 19% of all modern methods in 1989 to 55% in 2008–09 (NCPD and Institute for Resource
Development/Macro Systems 1989; KNBS and ICF Macro 2010). The trend has been accompanied by
declining use of pills (from 26% to 18%), IUDs (from 21% to 5%), and female sterilization (from 29% to 12%)
(NCPD and Institute for Resource Development/Macro Systems 1989; KNBS and ICF Macro 2010). Moreover,
the postpartum period is characterized by a limited range of available family planning methods that include the
lactational amenorrhea method (LAM), IUD, sterilization, progestin-only pills, injectables, and condoms. The
Ministry of Health (MOH) therefore recognizes the need for family planning information and services during the
postpartum period as an integral component of maternal and neonatal care services (DRH/MOPHS 2010).
Programs to strengthen family planning service provision during the postpartum period have to date been
implemented on a pilot basis in selected districts with limited stakeholder involvement to ensure sustainability
(Mwangi et al. 2008; Chebet and Jahonga 2011). These programs have, however, demonstrated substantial
improvements in the uptake of family planning in the postpartum period (Mwangi et al. 2008; Chebet and
Jahonga 2011).
Regarding breastfeeding practices, estimates from the 2008–09 KDHS showed that nearly all children under
five years of age (97%) were ever breastfed (KNBS and ICF Macro 2010). Mothers initiated breastfeeding
within one hour of birth for 58% and within one day of birth for 86% of the children ever breastfed (KNBS and
ICF Macro 2010). The median duration for any breastfeeding was 21 months, while the median duration for
exclusive breastfeeding was less than one month (KNBS and ICF Macro 2010). Ninety-three percent of
children under the age of 6 months were breastfed 6 or more times within a 24-hour period, while 32% of
children under the age of 6 months are exclusively breastfed (KNBS and ICF Macro 2010). In September
2012, parliament passed a law aimed at promoting exclusive breastfeeding for the first 6 months and
continuous breastfeeding after the introduction of other foods up to a period of 24 months. The law was,
however, criticized for seeking to regulate the marketing, promotion, distribution, and sale of breast milk
substitutes rather than promote exclusive breastfeeding (Maina 2012). The government has also formulated
several policies aimed at protecting, promoting, and supporting optimal infant feeding practices (Republic of
Kenya 2012).
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Methods
STUDY DESIGN
The study used both prospective and cross-sectional designs. The prospective component involved enrolling
and following up participants over a period of 6 months (2 ring cycles) or up to discontinuation of use of the
ring. Participants were interviewed at the time of recruitment (baseline), at 3 months and 6 months if they
completed the two ring cycles, or at the time they left the study if they discontinued use. Providers who were
trained on the provision of the method were also interviewed at baseline and endline. The cross-sectional
component involved interviews with women who were counseled on the ring but did not choose it at baseline
as well as community opinion leaders and husbands of PVR users at endline.

STUDY SETTING
The study was conducted in six public health facilities (two health centers and four hospitals) in three counties
in Kenya (Kiambu, Muranga, and Nairobi). The sites were selected in conjunction with the MOH/Kenya based
on onsite availability of postpartum family planning services, a reasonable caseload of women seeking family
planning before nine weeks postpartum, no other new contraceptive being introduced, the feasibility of
following up participants, being project sites of the Urban Reproductive Health Initiative (URHI), ability to meet
Population Council research standards and global Good Clinical Practice (GCP) guidelines, as well as the ability
to absorb the workload necessitated by the study such as documentation and client follow-up. Three of the
sites were located in rural areas, two in urban areas and one in a peri-urban setting. Throughout this report,
the term “site” or “study site” is used to refer to the health facilities where the study was conducted.

STUDY PROCEDURES
The study was preceded by a mapping exercise that involved consultative meetings with key government,
regulatory, and development agencies; social marketing organizations; research institutions;
manufacturers/distributors of health commodities; community/advocacy groups; institutions involving
public/private partnerships; and other organizations providing family planning services in the country. The
purpose of the exercise was to determine the perspectives of the stakeholders regarding the method and the
acceptability study. The next step involved obtaining the ethical, research, and regulatory approvals necessary
for importation of rings into the country and for conducting the study. Ethical clearance for the study was
granted by the Institutional Review Board (IRB) of the Population Council (Protocol number 562) and the Ethics
and Research Committee (ERC) of Kenyatta National Hospital/University of Nairobi (Protocol number
P625/11/2012). The National Commission for Science, Technology and Innovation (NACOSTI) granted the
research permit for the study (Reference number NCST/5/002/R/683), while the Pharmacy and Poisons
Board (PPB) granted the regulatory approval (Reference number PPB/ECCT/13/03/01/2013(93) and import
license (Number T/13/6357P). The import license allowed for importation of a limited quantity of rings for
research purposes only.
A total of 35 service providers from the six selected sites and four health managers/supervisors were trained
on the provision of PVR. The training was organized in two separate sessions and involved approximately three
providers from each health facility to avoid interfering with normal service delivery that could occur if all service
providers were trained at the same time. The providers were trained on PVR and how it works, the counseling
process, enrollment procedures (inclusion and exclusion criteria), good clinical practice, and completion of the
relevant documentation during recruitment. Six research assistants who had social science backgrounds were
also trained to conduct interviews with clients upon exit and during follow-up. The research assistants were
trained on the method and how it works, study design, interviewing skills, and ethical considerations in the
study. All research assistants undertook online courses on ethics and obtained certifications before being
assigned to the facilities. They were stationed at the facilities throughout the duration of the study.
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Recruitment of participants into the study started in November 2013 following the training of providers
and research assistants and ended in early February 2014 when the target was realized. A total of 58
clients aged 18–35 years were targeted for enrollment for quantitative interviews. A similar sample size
was targeted in each of the other two countries included in the study (Nigeria and Senegal). The sample
size was, however, powered to detect significant differences in all the three countries combined rather
than at the individual country level. Another five participants were targeted for enrollment for in-depth
interviews (IDIs) after one month of using the ring, at three months, and at six months. The study further
targeted 58 participants who were counseled on the ring but did not choose the method, in order to
understand the reasons guiding their choices.
The recruitment process entailed providers counseling postpartum clients seeking family planning
services on all available methods including PVR so that all clients had a choice of methods. Clients who
were identified from other units, such as immunization and growth monitoring, were encouraged to visit
the family planning unit if they needed contraceptive services. Clients who chose the ring during
counseling were directed to the research assistant who completed the written informed consent process
before providers could dispense the method. Clients were informed about the study procedures including
the requirement to undergo pregnancy and HIV tests as part of inclusion and exclusion criteria as well as
the need for follow-up. Those clients who granted written informed consent were then directed back to
the provider for medical examination. Clients who qualified for the ring after satisfying the inclusion and
exclusion criteria were then specifically counseled on the method and shown how to use it.
Providers were instructed to show enrolled participants how to insert and remove the ring, and to ensure
that they left the facility when the ring was properly inserted. In particular, providers were trained to insert
the ring, ask participants to remove it and reinsert themselves, and confirm that they were not feeling it
after reinsertion before leaving the facility. Clients who did not grant written informed consent and those
who did not satisfy the inclusion and exclusion criteria after screening were offered other methods, even
if they had initially chosen the ring. Clients who were given the ring were then interviewed by the research
assistants upon exit. They were advised to return to the facility after three months with the used ring to
obtain another one, or at any time in case of concerns regarding the use of the ring. During exit
interviews, the research assistants obtained contact information to follow up with the clients in the event
that they did not return to the study site.
Given that the ring was being introduced in the context of a study, there were elaborate inclusion and
exclusion criteria as outlined in Appendix A1. In addition, the study monitor conducted regular site visits
to ensure compliance with study procedures, good clinical practice, ethical conduct of the study, and
recordings of adverse and serious adverse events, if any. Participants were also instructed to report all
side effects including adverse or serious adverse events (AEs or SAEs), while providers were trained to
ask and record all side effects that women reported.

DATA COLLECTION
The first component of data collection involved information captured by service providers through case record
forms. These included forms for screening for eligibility, medical examination, concomitant prior medication,
unscheduled visits, follow-up visits, missed visits, unscheduled calls, pregnancy outcomes (in case a
participant became pregnant when using the ring), adverse events, serious adverse events, and termination of
participation in the study. Some of the forms, such as those for pregnancy outcomes, were not completed
because no participant experienced a pregnancy when using the ring.
The second component of data collection involved quantitative interviews with PVR users who were enrolled for
prospective follow-up (Table 1). The participants were interviewed upon exit at baseline and at three and six
months, or at study termination if they had discontinued. Baseline interviews captured information on
background characteristics (such as age, type of place of residence, education level, marital status,
occupation, and religious affiliation), reproductive history and preferences, contraceptive use, perceptions
9

about the quality of care received during the visit, as well as perceptions about the PVR and other vaginally
inserted products. Follow-up interviews captured information on the status of ring use, ease of use,
experiences of ring expulsion, general health status during ring use, sexual activity during ring use, and the
level of satisfaction with the method. Quantitative interviews were also conducted with consenting clients who
were counseled on the ring but did not choose to adopt it to capture information on their characteristics,
choice of method, and reasons guiding their choices.
The third component of data collection involved qualitative interviews with various stakeholders. In particular,
in-depth interviews (IDIs) were conducted with additional women who were enrolled in the study (Table 1). The
interviews were conducted at one, three, and six months following ring use. The interviews explored their
experiences using the ring and their perceptions about the method. In-depth interviews were also conducted
with three husbands of PVR users who informed their spouses that they were using the ring to determine their
perceptions about the method. In addition, three focus group discussions (FGDs) were held with community
stakeholders including religious leaders, women leaders, and youth leaders to determine their perceptions
about the method. All qualitative interviews and discussions were audiotaped and transcribed.
Service providers also completed self-administered questionnaires at the end of training (at baseline) and at
the end of participant follow-up (at endline). Information was collected on their background characteristics
(such as age, sex, and technical qualification), knowledge and practices regarding postpartum family planning
including PVR, perceptions about the method, and at endline, experiences dispensing the method to study
participants.

DATA MANAGEMENT AND ANALYSIS
Exit interviews with PVR users at baseline and endline were conducted using personal digital assistants (PDAs).
The data were then downloaded into computers at the Population Council office in Nairobi every Friday evening
during the study period. Data from case record forms and provider interviews were entered in EpiData in the
Population Council office. The case record forms were photocopied and copies were left at the participating
facilities together with participant files. All quantitative data were exported to Stata for cleaning and analysis.
Analysis involved simple frequencies.
Qualitative interviews were audiotaped, translated into English where necessary (for interviews that were
conducted in Kiswahili), and transcribed in Word. A “directed approach” to content analysis (Hsieh and
Shannon 2005) was employed for analyzing the interview transcripts: findings from the interviews’ major
domains of inquiry were used as guidance for initial codes, and this level of coding was used to generate
themes across all interviews with similar populations. These themes were taken to represent respondents’
general perceptions about the PVR and their experiences using it.
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Results
OVERALL STUDY METRICS
A total of 83 women were screened for eligibility for participation in the study after choosing the ring during
counseling (Table 1). Out of these, 78 were targeted for inclusion in quantitative interviews while 5 were
targeted for inclusion in in-depth interviews. Since information was not collected on the number of women
counseled on the method during the period of recruitment, it is not possible to determine the percent of
women coming for postpartum family planning who chose the PVR.
TABLE 1 Enrollment and participation in
the study
Variable
Number of women screened
Number of women enrolled
Number of women who completed the
study or used two rings
Number of PVR nonusers
interviewed at baseline
Data source: CRFs and Baseline surveys.

(n)
83
65
28
58

Sixty-five of the 83 women (78%) who were screened were
found to be eligible to participate in the study and were
therefore enrolled (Table 1). These comprised 60 of the 78
women (77%) who were targeted for inclusion in the
quantitative interviews and all women who were targeted
for inclusion in the in-depth interviews. A total of 28 (43%)
women who were enrolled in the study completed the two
ring cycles (Table 1). Twenty-four of the women who
completed the two ring cycles were included in the
quantitative interviews, while 4 were included in the indepth interviews.

DEMOGRAPHIC CHARACTERISTICS OF STUDY PARTICIPANTS
More than three-quarters of the women who were enrolled for
the quantitative interviews (77%) were aged 20–29 years (Table
2). More than two-thirds (67%) of the women were from urban or
peri-urban areas, 60% had a secondary and above level of
education, while nearly all (98%) were either married or living
with a man. Half of the women (50%) were not working,
although partners of 93% of them were engaged in some kind of
work with the majority (75%) of the partners being engaged in
nonprofessional jobs such as manual/casual work and business
or farming (Table 2).
Further analysis showed that, as expected, there were variations
in educational attainment by type of place of residence. In
particular, only half (50%) of the rural residents had a secondary
and above level of education, while about two-thirds of urban
and peri-urban residents had that level of education (67% and
64%, respectively). In contrast, the proportion of respondents
that were not working was highest in the urban areas and lowest
in peri-urban areas (56% in urban areas, 50% in rural areas, and
45% in peri-urban areas). However, all women who lived in
urban areas reported that their partners were engaged in some
form of work, while the corresponding proportions for peri-urban
and rural residents were 91% and 90%, respectively.

TABLE 2 Demographic characteristics of study
participants
Variable
Age
18–19
20–24
25–29
30–35
Place of residence
Urban
Peri-urban
Rural
Education
Primary or lower
Secondary
College/university
Marital status
Never married
Married
Cohabiting
Respondent’s occupation
Not working
Nonprofessional
Professional
Partner’s occupation
Not working
Nonprofessional
Professional
Total

(n)

Percent

4
31
15
10

6.7
51.7
25.0
16.7

18
22
20

30.0
36.7
33.3

24
26
10

40.0
43.3
16.7

1
58
1

1.7
96.7
1.7

30
26
4

50.0
43.3
6.7

4
45
11
60

6.7
75.0
18.3
100.0

Data source: Baseline dataset.
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REPRODUCTIVE AND FAMILY PLANNING HISTORY
Nearly half of the women (47%) who were enrolled in the study had given birth to one child and almost a
similar proportion (48%) had one living child (Table 3). The majority (63%) reported that the pregnancy for the
current child was intended, although most of the women (71%) desired to space the next pregnancy by at least
four years. The majority (89%) reported discussing pregnancy spacing with their partners. In addition, 37% of
the women were new family planning users (Table 3).
Further analysis showed that the proportion
of new users was higher among younger
(below 25 years of age) women than older
(25 years and above) women (49% and
20%, respectively). Similarly, the proportion
of new users was about five times higher
among women who had given birth to one
child than among those who had two or
more children (64% and 13%, respectively).

TABLE 3 Reproductive history and family planning use
Variable

(n)

Percent

28
20
12

46.7
33.7
20.0

29
19
12

48.3
31.7
20.0

38
22

63.3
36.7

14
23
12

28.6
46.9
24.5

50
6

89.3
10.7

Children ever born
1
2
3 or more
Number of living children
1
2
3 or more
Pregnancy was intended
Yes
No
Preferred spacing of next birth
2–3 years
4–5 years
6 years or more
Discussed pregnancy spacing with partner
Yes
No
Prior use of a method
Ever used
Never used

The proportion of new users was
also highest in the urban areas
(44%), followed by rural (35%) and
peri-urban areas (31%). Similarly,
the proportion of new users was
more than twice as high among
those with primary or lower levels of
education (55%) compared with
those with a secondary and above
level of education (25%).

Among women who had previously used a
method, the pill was the most common
38
63.3
method ever used (55%), followed by
22
36.7
injectables (45%), implants (10%), and
Data source: Baseline dataset (N=60).
emergency pills (8%) (Figure 1). As already
noted, the contraceptive method mix in Kenya has been characterized by a declining use of pills, intrauterine
contraceptive devices (IUDs), and female sterilization, and an increasing use of injectables.

FIGURE 1 PREVIOUS METHOD USE
Female condoms

2.6

IUDs/Coils

5.3

Male condoms

5.3

Emergency pills

7.9

Implants

10.3

Injectables

44.7

Pills

55.3

0

20

Percent

40

60

Note: Question allowed for multiple responses. Data source: Baseline dataset (N=38).

12

METHOD CHOICE AMONG PVR USERS AND NONUSERS
Ninety-five percent of the women chose the ring as the preferred method, while 5% chose it because their
preferred method (progestin-only pills) was not available at the time of the visit. The most common reasons for
choosing the ring as the preferred method were that it is user-controlled (49%); the perception that it did not
have many side effects (46%); the perception that it was safe for breastfeeding (18%); perceived ease, comfort
and convenience associated with the method (16%); and the desire to try a new method (14%) (Figure 2).

FIGURE 2 REASONS FOR PVR CHOICE
User-controlled

49.1

Not many side effects

45.6

Safe for breastfeeding

17.5

Ease/comfort/convenience

15.8

Try a new method

14.0

Other

14.0

It is free

8.8

It is short lasting

7.0
0

10

20

30 40
Percent

50

60

Note: Question allowed for multiple responses. Data source: Baseline
dataset (N=57).

Among women who were counseled on the ring but did not choose it and who agreed to be interviewed upon
exit, the majority (47%) chose injectables, 34% chose progestin-only pills, 12% chose implants, 3% chose male
condoms, 2% chose intrauterine contraceptive devices (IUDs), and another 2% opted to use the lactational
amenorrhea method (LAM). The most commonly cited reason for choice of a particular method was that they
had known it from before (39%) (see Figure 3). Other reasons (35%) included few or no side effects,
convenience of use including secret use without partner’s knowledge, preference for long-term methods, and
the desire to try another method.

FIGURE 3 REASONS FOR CHOOSING
OTHER METHODS
Ease of use

12.2

Someone used it

14.3

Other

34.7

Knew it before

38.8
0

10

20

30

40

50

Percent
Data source: Nonuser dataset (N=58).
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IMPRESSIONS ABOUT THE RING
There were remarkable changes in participants’ perceptions about the ring between baseline and follow-up.
For instance, half of the participants (50%) felt that the ring was too big at baseline, while at follow-up the
majority of the women interviewed (93%) reported that the size of the ring was just fine (Table 4). Similarly, the
proportion of participants who felt that the color of the ring was just fine increased from 78% at baseline to
93% at follow-up. In addition, the proportion that felt that the texture of the ring was just fine increased from
53% at baseline to 86% at endline (Table 4).
TABLE 4 Impressions about the ring
Indicator
Impressions about size
Too small
Too big
Just fine
Impressions about color
Too bright
Just fine
Impressions about texture
Too soft
Too hard
Just fine

Baseline, % (N=60)

Follow-up, % (N=42)

1.7
50.0
48.3

0.0
7.1
92.9

21.7
78.3

7.1
92.9

23.3
23.3
53.3

11.9
2.4
85.7

Data source: Baseline and follow-up datasets.

Further analysis showed that there were no significant differences in participants’ perceptions about the ring at
baseline by whether they completed the two ring cycles. In particular, half of the 28 women who completed the
two ring cycles and a similar proportion of those who discontinued use felt that the size of the ring was just
fine, while 40%, or 4 women who were eventually lost to follow-up, felt that way. Similarly, the proportion of
women who felt that the color of the ring was just fine was 81% among those who completed the two cycles,
79% among those who discontinued use, and 70% among those lost to follow-up. The corresponding figures
for those who felt that the texture of the ring was just fine were 58%, 54%, and 40% among the three groups of
participants respectively.

PERCEIVED QUALITY OF CARE
Interviews with participants upon exit during recruitment showed that 85% of the respondents reported that
providers had counseled them about breastfeeding requirements when using the ring (Table 5). Nearly all
participants (97%) reported that providers counseled them on how and when to remove the ring, while all
participants were given opportunity to ask questions. More than three-quarters (77%) of participants were
encouraged to insert the ring themselves. All participants reported that they were shown how to insert the ring,
while 73% reported that providers showed them how to remove the ring (Table 5). However, some providers
reported that a few clients were reluctant to touch their own genitals and expected the providers to insert the
ring for them just like they do with other methods requiring insertion, such as the IUD and implants.
TABLE 5 Perceived quality of care
Domain

Item

Counseling on
the PVR
method

Provider conveyed minimum breastfeeding
requirement
Provider conveyed when to remove PVR
Provider allowed respondent to ask questions
Provider encouraged respondent to insert PVR

Yes

51

85.0

Yes
Yes
Yes

58
60
46

96.7
100.0
76.7

Counseling on
PVR use

Provider showed how to insert PVR
Provider showed how to remove PVR

Yes
Yes

60
44

100.0
73.3

Data source: Baseline dataset.
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Response

(n)

Percent

ACCEPTABILITY
Eighty-percent of participants who were interviewed upon follow-up reported that they were satisfied with the
ring. The proportion reporting satisfaction with the ring was nearly twice as high among those who completed
the two ring cycles (100%) than among those who terminated use (57%). Table 6 presents the distribution of
participants who expressed satisfaction and dissatisfaction with the ring by experiences of using the method. A
similar proportion of satisfied and dissatisfied participants found it easy to insert the ring (76% and 75%,
respectively). However, a higher proportion of dissatisfied participants compared to their satisfied counterparts
found it easy to remove the ring (75% and 51%, respectively) and to reinsert the ring (100% and 54%,
respectively). None of the satisfied and dissatisfied clients reported experiencing side effects, which could
imply that participants who terminated use because of side effects were not interviewed at follow-up.
TABLE 6 Responses by satisfaction related to PVR use
Domain

Item

Response

Satisfied

Not Satisfied

p Value
Fisher’s Exact Test

Ease of use

Ease of inserting PVR
Ease of removing PVR
Ease of reinserting PVR

Easy/Very easy
Easy/Very easy
Easy/Very easy

Side effects

Reported

Expulsion

PVR fell out on its own

75.7%
51.4%
54.1%

75.0%
75.0%
100.0%

0.82
0.30
0.08

No

100.0%

100.0%

—

No

86.1%

66.7%

0.40

Partner feels PVR during sex
Change in frequency of sex
Change in sexual pleasure

No
No
No change
Increase

88.6%
62.9%
62.9%
34.3%

50.0%
25.0%
75.0%
25.0%

0.00
0.29
0.18
1.00

Will use in future

Interested

Yes

91.8%

50.0%

0.00

Partner/family
would support use

Reported

Yes

86.5%

0.0%

0.00

Will recommend

Reported

Yes

91.9%

50.0%

0.03

Already
recommended

Reported

Yes

73.0%

50.0%

0.04

Willingness to pay

Interested

Yes

76.5%

0.0%

0.07

Sexual intercourse Feel PVR during sex

Data source: Follow-up dataset.

The results in Table 6 further show that a higher proportion of satisfied than dissatisfied participants did not
experience expulsions (86% and 67%, respectively), did not feel the ring during sexual intercourse (89% and
50%, respectively), did not report partners feeling the ring during sexual intercourse (63% and 25%,
respectively), and indicated that their sexual pleasure increased during the time they were using the ring (34%
and 25%, respectively). In addition, a higher proportion of satisfied than dissatisfied participants reported that
they would use the ring in the future (92% and 50%, respectively), their partners and family members would
support them in using the ring in the future (87% versus 0%, respectively), they would recommend the use of
the ring to friends and family members (92% and 50%, respectively), they had already recommended the ring
to family members or friends (73% and 50%, respectively), and that they would be willing to pay for the method
(77% and 0%, respectively). Further analysis showed that those who reported willingness to pay for the method
cited amounts ranging from KSh. 50 (~US$0.50) to KSh. 1,000 (~US$10) with a median of KSh. 200 (~US$2).
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Providers further reported that they received clients who were often referred by PVR users asking for the ring.
They further reported that some of the participants who had completed the two ring cycles wanted another ring
(which could not be provided outside the context of the study). Some of the participants also wanted a ring that
could be used for one year or more.

WOMEN PARTICIPANTS
Satisfaction with the ring was also evident from the in-depth interviews with clients who were enrolled for
qualitative interviews as exemplified by the excerpts in Table 7.
TABLE 7 Responses by satisfaction related to PVR use
Domain

Comments

Perceptions of
PVR

It’s easy to use it, especially compared to the pill. You don’t
“forget” to take it, because it’s always there. (PVR User, Kiambu
County)
It can be removed … that is one of the things that made me like
it…. [If] I feel that it is not good for me, then I can remove it and
shift to another [method]. (PVR User, Nairobi County)

Partner’s feelings about PVR

We were discussing this and he was saying that that is the best
method because with the others I’ve had abdominal pain,
bleeding, and so on. Also, when using the other methods,
sometimes you feel like you don’t want to have sex, but with the
ring I was very okay. (PVR User, Kiambu County)

Sharing experiences with
friends

I told them it’s good. It’s stress-free and doesn’t have sideeffects, like headaches. (PVR User, Kiambu County)

Data source: In-depth interviews with women.

MALE PARTNERS
Male partners of PVR users also found the ring acceptable and recommended a longer-lasting ring as shown by
the quotes in Table 8.
TABLE 8 Responses by satisfaction related to PVR use
Domain

Perceptions of PVR

Comments

I liked it. It didn’t interfere with breast-milk production or the
sexual desire of my wife. I only wish that a long-acting PVR is
introduced. That would help us a lot. (Partner of PVR User,
Kiambu County)
It’s very beneficial and user-friendly; it also does not interfere
with the flow of breast milk. (Partner of PVR User, Nairobi
County)

Recommendations for
the future

The ring should be made as an annual one that should be
removed after one year. (Partner of PVR User, Kiambu
County)

Data source: In-depth interviews with husbands.
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PROVIDERS’ IMPRESSIONS
Interviews with providers showed notable changes in their perceptions about the ring between baseline and
endline. At endline, all providers reported that the ring was safe for postpartum women and for the infant and
that they would recommend it to family members or friends (Table 9). In contrast, slightly more than half of the
providers (57%) felt that the ring was safe for postpartum women and the infant at baseline, while less than
9% indicated that they would recommend it to family members or friends. Similarly, nearly all providers (97%)
at endline indicated that women in their locality would like the ring compared with just about half at baseline. A
similar proportion of providers (97%) reported at endline that they would prescribe the ring to lactating women
after the study ends.
The results in Table 9 further show that there were notable changes between baseline and endline in the
proportion of providers that reported that community health workers should be allowed to dispense the ring
(from 17% to 67%), the ring does not affect sexual pleasure (from 51% to 83%), the ring does not interfere with
sexual intercourse (from 57% to 93%), they would dispense the ring to lactating unmarried women with no
contraindications (from 9% to 87%), and that they would not require the husband’s consent before dispensing
the ring (from 9% to 83%). In addition, most of the providers (93%) reported at endline that they did not receive
any complaints from husbands/partners of study participants regarding the use of the ring, while about half
(53%) reported that they did not receive any complaints from users. The smallest increase was in the
proportion of providers who felt that the ring does not increase risk of vaginal or pelvic infections (from 37% at
baseline to 57% at endline).
TABLE 9 Providers’ responses by satisfaction related to PVR use
Domain

Baseline
(N=35)

Endline
(N=30)

PVR is safe for postpartum women

57.1%

100.0%

PVR is safe for baby

57.1%

100.0%

PVR does not increase risk of vaginal/pelvic infections

37.1%

56.7%

Lactating women in the locality would like PVR

54.3%

96.7%

Community health workers should be allowed to dispense PVR

17.1%

66.7%

PVR does not affect sexual pleasure

51.4%

83.3%

PVR does not interfere with sexual intercourse

57.1%

93.3%

Would recommend PVR to family members/friends

8.6%

100.0%

Would provide PVR to unmarried women with no contraindications

8.6%

86.7%

Would not require husband’s consent before dispensing PVR

8.6%

83.3%

Did not receive any complaints from clients regarding PVR use

—

53.3%

Did not receive any complaints from spouses/partners regarding PVR
use

—

93.3%

Would prescribe PVR to lactating women after the study ends

—

96.7%

Data source: Provider interviews at baseline and endline.
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COMMUNITY STAKEHOLDERS
Findings from focus group discussions with community stakeholders showed that the ring was acceptable for
various reasons, including convenience and ease of use, as shown by the quotes in Table 10.
TABLE 10 Responses by satisfaction related to community members’ PVR use
Domain

Comments

Perceptions of PVR

[The PVR] is the best way since it will not cause any problems even if
breastfeeding. Breastfeeding women can sometimes get pregnant before 6
months and that is a problem for men since they will be denied sex with
women. (Community Leaders, Kiambu County)
[The PVR] will be considered easy and cheap to use. Women have a lot of
issues: You will find that your husband was out on a trip, comes back
abruptly, and wants to leave just as quickly. Then you realize that you
haven’t taken your pill and he wants to have sex. Do you think you’ll tell him
to wait until you take the pill first when you’ve probably been hiding it from
him? Definitely not. So, to avoid such awkward moments, I would rather use
the vaginal ring to be safe at all times. (Community Leaders, Nairobi County)

Data source: Focus-group discussion.

PARTNERS’ SUPPORT AND EXPERIENCE
Half of the participants who were interviewed
during follow-up and who reported that they had
FIGURE 4 PARTNERS’ REACTIONS ON
resumed sexual intercourse indicated that their
PVR USE
partners felt the ring (Figure 4). Slightly more
than one-third (36%) indicated that the ring
negatively affected their partners’ sexual
Partners' sexual pleasure
40.9
increased
pleasure, with 41% indicating that the partners’
Ring negatively affected
sexual pleasure increased. Further analysis
36.4
partners' sexual pleasure
showed that a higher proportion of participants
who completed the two ring cycles, compared
Partner felt the ring during sex
50.0
with those who terminated use, reported that
their partners felt the ring during sexual
0
20
40
60
Percent
intercourse (52% and 47%, respectively); that the
Data source: Follow-up dataset (N=44).
ring affected their partners’ sexual pleasure (40%
and 32%, respectively); and that their partners’
sexual pleasure increased (56% and 21%, respectively).
Increase in partners’ sexual experience was further reflected in the in-depth interviews. As one user who was
enrolled for in-depth interviews put it:
I can tell women [that] if they use [the ring], even their husbands will say, “Ah! ... the act in bed … they
[men] say it’s good … He says it’s because of the ring. (In-depth interview, Kiambu County)
Field reports also showed that a few participants were accompanied by their spouses who helped in decisionmaking regarding the choice of the ring. In one case, a participant who had completed the two ring cycles and
switched to another method was told by the husband to return to the facility and take up another ring.
However, there were also a few participants who after being counseled, reported that they had to consult their
husbands before they could take up the ring. In addition, as already noted, one client discontinued use
because she reported that her husband was not comfortable with the ring.
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DISCONTINUATION
Twenty-six of the 60 participants (43%) who enrolled for follow-up completed two ring cycles, 24 (40%)
discontinued use for various reasons (Figure 4), while 10 (17%) were lost to follow-up. Table 11 presents the
distribution of participants who completed the two ring cycles and those who terminated use by experiences
with the ring. The proportion of participants who found the ring easy to insert was higher among those who
completed the two ring cycles than among those who terminated use (77% and 63%, respectively). In contrast,
the proportion of participants who found the ring easy to remove was higher among those who terminated use
than among those who completed the two ring cycles (54% and 46%, respectively). Similarly, all women who
completed the two ring cycles did not experience expulsion. The proportion that did not experience expulsion
was much lower among those who terminated use (68%).
TABLE 11 Responses by continuation related to PVR use
Domain

Item

Response

Continued
(N=26)

Terminated
(N=24)

Fisher’s Exact Test

P Value

76.9%
46.2%
53.9%

62.5%
54.2%
54.2%

0.36
0.78
1.00

Ease of use

Ease of inserting PVR
Ease of removing PVR
Ease of reinserting PVR

Easy/Very easy
Easy/Very easy
Easy/Very easy

Expulsion

PVR fell out on its own
Frequency of feeling the PVR

No
No, never

100.0%
68.0%

68.4%
52.6%

0.00
0.36

Sexual
intercourse

Feel PVR during sex
Partner feels PVR during sex
Removal during sex
Change in frequency of sex
Change in sexual pleasure

No
No
No
No change or increase
No change or increase

92.0%
76.0%
100.0%
96.0%
96.0%

57.9%
31.6%
94.7%
84.2%
73.7%

0.01
0.01
0.43
0.30
0.07

Data source: Baseline and follow-up datasets.

The results in Table 11 further show that the proportion of participants who did not feel the ring during sex was
higher among those who completed the two ring cycles than among those who terminated use (92% and 58%,
respectively). Similar differences between those who completed two ring cycles and those who terminated use
were noted in the proportion of participants whose partners did not feel the ring during sex (76% and 32%,
respectively) as well as those who did not experience any change or experienced an increase in the frequency
of sex (96% and 84%, respectively) or sexual pleasure (96% and 74%, respectively).
The most common reason for
discontinuing use of the ring was
expulsion (Figure 5). Another 10
participants were lost to follow-up having
moved out of the study setting or due to
incorrect contact information, while 5
discontinued use because they reported
experiencing side effects including
abdominal pain, vaginal bleeding, and
loss of libido. Three participants were
discontinued due to non-adherence to
study procedures, because they left the
ring out for more than two hours. One
participant stopped use because she
associated the illness of one of her twin
babies to the use of the ring (i.e.,
misconception about the method).

FIGURE 5 REASONS FOR DISCONTINUING PVR
Misconception about method

1

Serious adverse event

1

Husband/partner discomfort

1

Mother-in-law opposition

2

Non-adherence to procedures

3

Side effects

5

Loss to follow-up

10

Expulsion of ring

11

0

5

10

Number of cases

15

Data source: Follow-up dataset (N=34).
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Figure 6 presents the distribution of participants
who completed the two ring cycles and those who
terminated participation but were interviewed at
follow-up by type of method they switched to. The
proportion of participants who switched to
injectables was higher among those who
terminated use than among those who completed
the two ring cycles (72% and 6%, respectively). In
contrast, the proportion of participants who
switched to implants was higher among those who
completed the two ring cycles than among those
who terminated use (56% and 17%, respectively).
Similar variations were noted with respect to
switching to the IUD (25% among those who
completed the two ring cycles compared with 6%
among those who terminated use).

FIGURE 6 METHOD SWITCH
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Data source: Follow-up dataset (N=43).

Further analysis showed that the proportion of participants who had ever used injectables was almost similar
among those who completed the two ring cycles and those who terminated use (40% and 38%, respectively).
However, a higher proportion of participants who completed the two ring cycles had ever used pills compared
with those who terminated use (67% and 38%, respectively). A similar pattern was noted for the IUD, with 13%
of those who completed the two cycles having previously used the method compared with none among those
who terminated use. In contrast, the proportion that had ever used implants was nearly twice as high among
those who terminated use compared with those who completed the two cycles (13% and 7%).

ADVERSE AND SERIOUS ADVERSE EVENTS
Tables 12 and 13 list the adverse and serious
adverse events that occurred in the course of the
study. There were a total of three adverse events and
one serious adverse event. The first adverse event
was a mild urinary tract infection, which was treated.
The provider determined the relationship of the
condition with the product as “possible.” However,
the participant continued using the ring and
completed the two ring cycles.
The second adverse event involved complaints about
lower abdominal pains, which the provider
determined did not require treatment but was
possibly related to the study product. The participant
also reported that her husband had told her to
remove the ring as a result. Her participation in the
study was therefore terminated.

TABLE 12 Adverse events
Number

Description

Treatment

KE14104
KE14108
KE16101

Mild urinary tract infection
Lower abdominal pain
Prolonged bleeding

Treated and discharged
No treatment required
Treated and discharged

Data source: Case record forms.

TABLE 13 Serious adverse events
Number

Description

Treatment

KE16102

Severe headache
and psychosis

Treated in a
nonparticipating facility

Data source: Case record forms.

The third adverse event involved prolonged bleeding, which the provider determined was possibly related to the
study product. The participant sought treatment from a nonparticipating facility where she was advised to remove
the ring. The provider therefore decided to terminate her participation in the study. The condition for the serious
adverse event could not be conclusively determined because the participant sought care from a nonparticipating
facility. The case was, however, considered a serious adverse event because the participant was hospitalized
while still in the study. The study team realized that there was a serious adverse event when the client failed to
return for a scheduled visit and attempted to follow up. However, the provider indicated that the condition was
severe headache and psychosis based on the report of the mother-in-law and that it was unlikely related to the
study product. The information was shared with the Population Council’s Safety Desk for determination as well.
The Safety Desk then developed a report, which was shared with the local regulatory authorities.
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Discussion
ACCEPTABILITY
A number of key findings emerged from this study that will be useful for future introduction efforts. Most
importantly, the ring was acceptable to most users, partners, providers, and other community members. The
majority of participants who completed the two ring cycles indicated that they would use the ring in the future,
their partners or family members would support future use, they would recommend or had already
recommended the ring to their friends or family members, and that they were willing to pay for the method. In
addition, some clients were encouraged by their spouses to use the ring. There were also remarkable positive
changes between baseline and follow-up in the perceptions of participants and providers about the ring. These
are indications that the ring was acceptable to clients and key stakeholders. Acceptability of the ring to clients
and key stakeholders is, in turn, important for informing the introduction of the method into the country.
Several attributes associated with the ring are likely to contribute to increased uptake of the method. The most
commonly cited reason for the choice of the ring among users was that the method is user-controlled. Most
users also found the ring easy to insert, remove, and reinsert. Such attributes are likely to increase the uptake
of the method in the country. This is also consistent with findings from studies in other settings such as
Australia, Canada, Chile, the Dominican Republic, and the United States that found that women liked vaginal
rings for the same reasons (RHSC 2011).
In addition, the majority of users were young, educated, urban or peri-urban dwellers. The majority of women
who chose the ring were aged 20–29 years, had at least secondary level education, and resided in urban or
peri-urban areas. In addition, the majority of PVR users had given birth to at least two children and wanted to
space the next birth by at least four years. These findings are consistent with those of market segmentation
analysis of existing Demographic and Health Survey data using a needs-based approach, which showed that
most users of the ring are likely to have these attributes (Obare et al. 2014). The findings suggest that these
categories of clients are likely to be the first acceptors of the method if it is introduced into the country before
usage diffuses to other segments of the population.
Next, the PVR is likely to expand contraceptive choices during the postpartum period. The second major reason
for choosing the ring was the perception of fewer side effects. In addition, some clients chose the ring just to
try a new method, while others chose it because their preferred method was not available at the time of the
visit. Given that the postpartum period is characterized by high unmet need for contraception and a limited
range of available methods, expanding contraceptive choices for postpartum women has been a key priority of
the Ministry of Health (DRH 2010; KNBS and ICF Macro 2010).
Expanding method choices is likely to sustain or to contribute to an increased contraceptive prevalence rate.
Slightly more than one-third of PVR users were new family planning users. The goal of the Ministry of Health
was to achieve a contraceptive prevalence rate of 56% by 2015. Findings from the 2014 KDHS showed that
the prevalence rate had increased to 58% from 46% in 2008–09 (KNBS and ICF Macro 2010; KNBS et al.
2015). By drawing in new users, the ring is likely to sustain the prevailing contraceptive prevalence rate or
contribute to a further increase provided efforts are put in place to support users and providers and to reduce
discontinuation.
Finally, the PVR is likely to bridge users to long-term methods, especially those involving insertion. The findings
of the study showed that those who completed two ring cycles were more likely to switch to implants or IUDs
compared with those who terminated use. Switching to long-term methods was also consistent with the finding
that most users wished to space the next pregnancy by at least four years. The finding further suggests that
the ring is likely to contribute to increased uptake of methods involving insertion and trained providers.
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LIMITATIONS
The above findings could be influenced by the following study limitations. The target sample size of 58 clients
for follow-up was small. However, as already noted, the sample size was powered to detect significant
differences for the three countries combined (Kenya, Nigeria, and Senegal) with 58 clients targeted in each
country. Given that the study involved prospective follow-up of clients, it was affected by loss to follow-up
mostly occasioned by participants moving out of the study area or providing incorrect contact information.
However, the rate of loss to follow-up (17%) was within the recommended minimum of between 20% and 30%
for cohort studies (Babbie 1973; Altman 2000). Finally, discontinuation was mainly due to experiences of ring
expulsion followed by side effects and non-adherence to use procedures. Ring expulsion and non-adherence to
use procedures were found to be the second most common reasons for termination of ring use in other studies
(Diaz et al. 1997; Sivin et al. 1997; Massai et al. 1999, 2005). The rate of discontinuation of ring use in the
study (40%) was also comparable to, or lower than, that of other methods in the country. For instance,
estimates from 2008–09 KDHS show that the rate of discontinuation was 29% for injectables, 43% for pills,
59% for condoms, and 36% for all methods (KNBS and ICF Macro 2010).

LESSONS LEARNED FOR FUTURE INTRODUCTION OF RINGS
The findings of the study have the following implications for future efforts geared toward introducing the ring in
the country:


Client counseling on proper use of the ring: Given that the ring is a user-controlled method, service delivery
programs should consider ways of ensuring that clients obtain information on correct use including proper
insertion and adherence to use instructions, such as not leaving the ring out for long. Proper insertion and
adhering to use instructions are, in turn, likely to reduce instances of ring expulsion and discontinuation.



Addressing misconceptions: Just like any other family planning method, programs delivering the ring need
to consider addressing misconceptions about the method. This was evident from the finding that one client
terminated use because she associated the illness of one of her twins with the use of the ring. In addition,
it is likely that those who terminated use because of the influence of mothers-in-law or spouses could
partly be due to misconceptions about the method on the part of these significant others.



Mechanisms for bridging users to long-term methods: It was evident that those who completed the two
ring cycles mostly switched to long-term methods at the end of the study. In addition, most users desired
longer birth spacing. Programs delivering the ring therefore need to consider mechanisms for bridging
users to long-term methods.
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Appendix
APPENDIX A1: INCLUSION/EXCLUSION CRITERIA
A.

INCLUSION CRITERIA
To participate in the study, a woman had to meet all the inclusion criteria listed below at enrollment:
1.
2.
3.
4.
5.
6.

7.
8.
9.
10.
B.

Able to provide informed consent
Age 18 to 35 years (inclusive)
Delivered a healthy singleton infant 6 to 9 weeks prior to study enrollment
Has at least (1) living child and is fully/nearly fully breastfeeding the new infant
Willing to continue breastfeeding infant a minimum of 4 times per day for at least 6 months.
Is in good health as confirmed by medical history, physical examination. (Includes vital signs and
diagnosis/treatment of vaginal infection per the standard of care in Kenya. Treatment of vaginal infection
is required prior to enrollment.)
Has or expects to have regular exposure to the risk of pregnancy
Willing to choose the PVR as contraceptive method
Willing and able to follow study procedures
Expects to continue living in an area accessible to the study site for the duration of the study.
EXCLUSION CRITERIA

Similarly, women with any of the following attributes were excluded from participating in the study:
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.

Is pregnant or suspected of being pregnant
Breastfeeding less than fully/nearly fully
Hypersensitivity to hormonal preparations or silicone rubber
HIV positive or in a discordant relationship
Presence of genital or urinary tract infection
Dyspareunia
History of Human Papillomavirus (HPV)
History of bacterial infections such as Chlamydia and gonorrhea
History of pelvic inflammatory disease (PID) or salpingitis since delivery
History of chronic constipation
Clinically relevant genital prolapse
Has history of generalized urticaria
Any chronic condition requiring continuous or regular use of medication or herbals prescribed by healers
Has a history of thrombophlebitis or thromboembolism
History of and/or current depression
History of epilepsy or convulsive disorder
Had an ectopic pregnancy
Has vaginal bleeding not attributable to menses
Known or suspected carcinoma of the breast
Has had any other known or suspected neoplasia within last 5 years
Not exposed to risk of pregnancy
Use of chronic medications, Rifampicin, Griseofluvin, barbiturates, phenytoin, ketoconozole, butazoliden
Confirmed hypertension (blood pressure—systolic more than 140 mmHg and/or diastolic more than 90
mmHg)
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